Periodontal Disease in Young Adults as a Risk Factor for Subclinical Atherosclerosis: A Clinical, Biochemical and Immunological Study (original) (raw)

Abstract

Although a strong relationship between periodontal disease (PD) and atherosclerosis was shown in adults, little data are published in younger PD patients. Therefore, this study aimed to investigate and correlate clinical parameters of PD, pro- and immunoregulatory cytokines in gingival crevicular fluid (GCF) and serum, biochemical and hematological parameters associated with atherosclerosis risk, and carotid intima-media thickness (IMT) in our younger study participants (n = 78) (mean age 35.92 ± 3.36 years) who were divided into two equal groups: subjects with and without PD. PD patients had higher values of IMT, hs-CRP, triglycerides, total cholesterol, and LDL; most proinflammatory and Th1/Th17-associated cytokines in GCF; and IL-8, IL-12, IL-18, and IL-17A in serum compared to subjects without PD. These cytokines in GCF positively correlated with most clinical periodontal parameters. Clinical periodontal parameters, TNF-α and IL-8 in GCF and IL-17A, hs-CRP, and LDL in serum, had...

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (92)

  1. Pavlic, V.; Peric, D.; Kalezic, I.S.; Madi, M.; Bhat, S.G.; Brkic, Z.; Staletovic, D. Identification of periopathogens in atheromatous plaques obtained from carotid and coronary arteries. Biomed Res. Int. 2021, 2021, 9986375. [CrossRef]
  2. Pucar, A.; Milasin, J.; Lekovic, V.; Vukadinovic, M.; Ristic, M.; Putnik, S.; Kenney, E.B. Correlation between atherosclerosis and periodontal putative pathogenic bacterial infections in coronary and internal mammary arteries. J. Periodontol. 2007, 78, 677-682. [CrossRef] [PubMed]
  3. Alsalleeh, F.; Alhadlaq, A.S.; Althumiri, N.A.; AlMousa, N.; BinDhim, N.F. Public Awareness of the Association between Periodontal Disease and Systemic Disease. Healthcare 2023, 11, 88. [CrossRef] [PubMed]
  4. Buhlin, K.; Hultin, M.; Norderyd, O.; Persson, L.; Pockley, A.G.; Rabe, P.; Klinge, B.; Gustafsson, A. Risk factors for atherosclerosis in cases with severe periodontitis. J. Clin. Periodontol. 2009, 36, 541-549. [CrossRef] [PubMed]
  5. Piconi, S.; Trabattoni, D.; Luraghi, C.; Perilli, E.; Borelli, M.; Pacei, M.; Rizzardini, G.; Lattuada, A.; Bray, D.H.; Catalano, M.; et al. Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J. 2008, 23, 1196-1204. [CrossRef]
  6. Schenkein, H.A.; Papapanou, P.N.; Genco, R.; Sanz, M. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontology 2000 2020, 83, 90-106. [CrossRef]
  7. Awan, Z.; Genest, J. Inflammation modulation and cardiovascular disease prevention. Eur. J. Prev. Cardiol. 2015, 22, 719-733.
  8. Nicolosi, L.N.; Lewin, P.G.; Rudzinski, J.J.; Pompeo, M.; Guanca, F.; Rodríguez, P.; Gelpi, R.J.; Rubio, M.C. Relation between periodontal disease and arterial stiffness. J. Periodontal. Res. 2017, 52, 122-126. [CrossRef]
  9. Wojtkowska, A.; Zapolski, T.; Wysoki ńska-Miszczuk, J.; Wysoki ński, A.P. The inflammation link between periodontal disease and coronary atherosclerosis in patients with acute coronary syndromes: Case-control study. BMC Oral Health 2021, 21, 5. [CrossRef]
  10. Del Giudice, C.; Vaia, E.; Liccardo, D.; Marzano, F.; Valletta, A.; Spagnuolo, G.; Ferrara, N.; Rengo, C.; Cannavo, A.; Rengo, G. Infective Endocarditis: A Focus on Oral Microbiota. Microorganisms 2021, 9, 1218. [CrossRef]
  11. Kinane, D.F.; Stathopoulou, P.G.; Papapanou, P.N. Periodontal diseases. Nat. Rev. Dis. 2017, 3, 1-14. [CrossRef]
  12. Könönen, E.; Gursoy, M.; Gursoy, U.K. Periodontitis: A multifaceted disease of tooth-supporting tissues. J. Clin. Med. 2019, 8, 1135. [CrossRef]
  13. Fatkhullina, A.R.; Peshkova, I.O.; Koltsova, E.K. The role of cytokines in the development of atherosclerosis. Biochemistry 2016, 81, 1358-1370. [CrossRef] [PubMed]
  14. Bundy, J.D.; Li, C.; Stuchlik, P.; Bu, X.; Kelly, T.N.; Mills, K.T.; He, H.; Chen, J.; Whelton, P.K.; He, J. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: A systematic review and network meta-analysis. JAMA Cardiol. 2017, 2, 775-781. [CrossRef]
  15. Fentoglu, O.; Bozkurt, F.Y. The bi-directional relationship between periodontal disease and hyperlipidemia. Eur. J. Dent. 2008, 2, 142-146. [CrossRef]
  16. Tang, K.; Lin, M.; Wu, Y.; Yan, F. Alterations of serum lipid and inflammatory cytokine profiles in patients with coronary heart disease and chronic periodontitis: A pilot study. J. Int. Med. Res. 2011, 39, 238-248. [CrossRef] [PubMed]
  17. Cairo, F.; Castellani, S.; Gori, A.M.; Nieri, M.; Baldelli, G.; Abbate, R.; Pini-Prato, G.P. Severe periodontitis in young adults is associated with sub-clinical atherosclerosis. J. Clin. Periodontol. 2008, 35, 465-472. [CrossRef]
  18. Cairo, F.; Nieri, M.; Gori, A.; Tonelli, P.; Branchi, R.; Castellani, S.; Abbate, R.; Pini-Prato, G.P. Markers of systemic inflammation in periodontal patients: Chronic versus aggressive periodontitis. An explorative cross-sectional study. Eur. J. Oral Implantol. 2010, 3, 147-153.
  19. Von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbroucke, J.P.; STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (strobe) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 2008, 61, 344-349. [CrossRef] [PubMed]
  20. Ramfjord, S.P. Indices for prevalence and incidence of periodontal disease. J. Periodontol. 1959, 30, 51-59. [CrossRef]
  21. Silness, J.; Löe, H. Periodontal disease in pregnancy (II). Correlation between oral hygiene and periodontal condition. Acta Odontol. Scand. 1964, 22, 121-135. [CrossRef] [PubMed]
  22. Löe, H.; Silness, J. Periodontal disease in pregnancy (I). Prevalence and severity. Acta Odontol. Scand. 1963, 21, 533-551. [CrossRef]
  23. Barnett, M.L.; Ciancio, S.G.; Mather, M.L. The modified papillary bleeding index: Comparison with gingival index during the resolution of gingivitis. J. Prev. Dent. 1980, 6, 135-138.
  24. Armitage, G.C. Development of a classification system for periodontal diseases and conditions. Ann. Periodontol. 1999, 4, 1-6.
  25. Güler, A.; Yılmaz, E.; Demir, A.; Bayıro glu, N.; Kalkan, A.K.; Uzun, F.; Ertürk, M. The relationship between the severity of atherosclerosis and periodontal disease index in diabetic patients. Koşuyolu Heart J. 2022, 25, 149-156. [CrossRef]
  26. Fatima, T.; Khurshid, Z.; Rehman, A.; Imran, E.; Srivastava, K.C.; Shrivastava, D. Gingival crevicular fluid (GCF): A diagnostic tool for the detection of periodontal health and diseases. Molecules 2021, 26, 1208.
  27. Zweig, M.H.; Campbell, G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin. Chem. 1993, 39, 561-577. [CrossRef] [PubMed]
  28. Unal, I. Defining an optimal cut-point value in ROC analysis: An alternative approach. Comput. Math Methods Med. 2017, 2017, 3762651. [CrossRef] [PubMed]
  29. Swets, J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240, 1285-1293. [CrossRef] [PubMed]
  30. Lamprecht, R.; Rimmele, D.L.; Schnabel, R.B.; Heydecke, G.; Seedorf, U.; Walther, C.; Mayer, C.; Struppek, J.; Borof, K.; Behrendt, C.; et al. Cross-sectional analysis of the association of periodontitis with carotid intima media thickness and atherosclerotic plaque in the Hamburg City health study. J. Periodontal. Res. 2022, 57, 824-834. [CrossRef] [PubMed]
  31. Almeida, A.P.C.P.S.C.; Fagundes, N.C.F.; Maia, L.C.; Lima, R.R. Is there an association between periodontitis and atherosclerosis in adults? A systematic review. Curr. Vasc. Pharmacol. 2018, 16, 569-582. [CrossRef] [PubMed]
  32. Zardawi, F.; Gul, S.; Abdulkareem, A.; Sha, A.; Yates, J. Association between periodontal disease and atherosclerotic cardiovascular diseases: Revisited. Front. Cardiovasc. Med. 2021, 7, 625579. [CrossRef]
  33. Cecoro, G.; Annunziata, M.; Iuorio, M.T.; Nastri, L.; Guida, L. Periodontitis, low-grade inflammation and systemic health: A scoping review. Medicina 2020, 56, 272. [CrossRef] [PubMed]
  34. Ramadan, D.E.; Hariyani, N.; Indrawati, R.; Ridwan, R.D.; Diyatri, I. Cytokines and chemokines in periodontitis. Eur. J. Dent. 2020, 14, 483-495. [CrossRef] [PubMed]
  35. Plemmenos, G.; Evangeliou, E.; Polizogopoulos, N.; Chalazias, A.; Deligianni, M.; Piperi, C. Central regulatory role of cytokines in periodontitis and targeting options. Curr. Med. Chem. 2021, 28, 3032-3058. [CrossRef] [PubMed]
  36. Cafiero, C.; Spagnuolo, G.; Marenzi, G.; Martuscelli, R.; Colamaio, M.; Leuci, S. Predictive Periodontitis: The Most Promising Salivary Biomarkers for Early Diagnosis of Periodontitis. J. Clin. Med. 2021, 10, 1488. [CrossRef]
  37. Patini, R.; Gallenzi, P.; Spagnuolo, G.; Cordaro, M.; Cantiani, M.; Amalfitano, A.; Arcovito, A.; Callà, C.; Mingrone, G.; Nocca, G. Correlation Between Metabolic Syndrome, Periodontitis and Reactive Oxygen Species Production. A Pilot Study. Open Dent. J. 2017, 11, 621-627. [CrossRef]
  38. Džopalić, T.; Tomić, S.; Bekić, M.; Vučević, D.; Mihajlović, D.; Eraković, M.; Čolić, M. Ex vivo study of IL-6 expression and function in immune cell subsets from human periapical lesions. Int. Endod. J. 2022, 55, 480-494. [CrossRef]
  39. Gencer, S.; Evans, B.R.; van der Vorst, E.P.C.; Döring, Y.; Weber, C. Inflammatory chemokines in atherosclerosis. Cells 2021, 10, 226. [CrossRef]
  40. Georgakis, M.K.; van der Laan, S.W.; Asare, Y.; Mekke, J.M.; Haitjema, S.; Schoneveld, A.H.; de Jager, S.C.; Nurmohamed, N.S.; Kroon, J.; Stroes, E.S.; et al. Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate with Plaque Vulnerability. Arter. Thromb. Vasc. Biol. 2021, 41, 2038-2048. [CrossRef]
  41. Słotwi ńska, S. Review paper. Cytokines and periodontitis. Part I: Interleukin-1 and interleukin-1 receptor antagonist. Cent. Eur. J. Immunol. 2012, 37, 173-177.
  42. Tawfig, N. Proinflammatory cytokines and periodontal disease. J. Dent. Probl. Solut. 2016, 3, 12-17. [CrossRef]
  43. Cardoso, E.M.; Reis, C.; Manzanares-Céspedes, M.C. Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases. Postgrad. Med. 2018, 130, 98-104. [CrossRef] [PubMed]
  44. Andrukhov, O.; Ulm, C.; Reischl, H.; Nguyen, P.Q.; Matejka, M.; Rausch-Fan, X. Serum cytokine levels in periodontitis patients in relation to the bacterial load. J. Periodontol. 2011, 82, 885-892. [CrossRef]
  45. Kusuhara, M.; Isoda, K.; Ohsuzu, F. Interleukin-1 and occlusive arterial diseases. Cardiovasc. Hematol. Agents Med. Chem. 2006, 4, 229-235. [CrossRef]
  46. Zhu, H.; Lin, X.; Zheng, P.; Chen, H. Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease. Int. J. Clin. Exp. Med. 2015, 8, 2214-2220.
  47. Marcaccini, A.M.; Meschiari, C.A.; Sorgi, C.A.; Saraiva, M.C.; de Souza, A.M.; Faccioli, L.H.; Tanus-Santos, J.E.; Novaes, A.B.; Gerlach, R.F. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J. Periodontol. 2009, 80, 594-602. [CrossRef]
  48. Kurita-Ochiai, T.; Jia, R.; Cai, Y.; Yamaguchi, Y.; Yamamoto, M. Periodontal disease-induced atherosclerosis and oxidative stress. Antioxidants 2015, 4, 577-590. [CrossRef]
  49. Yamaguchi, Y.; Kurita-Ochiai, T.; Kobayashi, R.; Suzuki, T.; Ando, T. Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis. Pathog. Dis. 2015, 73, ftv011. [CrossRef]
  50. Suh, J.S.; Kim, S.; Boström, K.I.; Wang, C.Y.; Kim, R.H.; Park, N.H. Periodontitis-induced systemic inflammation exacerbates atherosclerosis partly via endothelial-mesenchymal transition in mice. Int. J. Oral Sci. 2019, 11, 21. [CrossRef]
  51. Geginat, J.; Paroni, M.; Maglie, S.; Alfen, J.S.; Kastirr, I.; Gruarin, P.; De Simone, M.; Pagani, M.; Abrignani, S. Plasticity of human CD4 T cell subsets. Front. Immunol. 2014, 5, 630. [CrossRef]
  52. Yasuda, K.; Nakanishi, K.; Tsutsui, H. Interleukin-18 in health and disease. Int. J. Mol. Sci. 2019, 20, 649. [CrossRef]
  53. Okui, T.; Aoki-Nonaka, Y.; Nakajima, T.; Yamazaki, K. The role of distinct T cell subsets in periodontitis-studies from humans and rodent models. Curr. Oral Health Rep. 2014, 1, 114-123. [CrossRef]
  54. Stadler, A.F.; Angst, P.D.; Arce, R.M.; Gomes, S.C.; Oppermann, R.V.; Susin, C. Gingival crevicular fluid levels of cy- tokines/chemokines in chronic periodontitis: A meta-analysis. J. Clin. Periodontol. 2016, 43, 727-745. [CrossRef] [PubMed]
  55. Chen, X.T.; Chen, L.L.; Tan, J.Y.; Shi, D.H.; Ke, T.; Lei, L.H. Th17 and Th1 lymphocytes are correlated with chronic periodontitis. Immunol. Investig. 2016, 45, 243-254. [CrossRef] [PubMed]
  56. Whitman, S.C.; Ravisankar, P.; Daugherty, A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ. Res. 2002, 90, E34-E38. [CrossRef] [PubMed]
  57. Lockshin, B.; Balagula, Y.; Merola, J.F. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J. Am. Acad Dermatol. 2018, 79, 345-352. [CrossRef]
  58. Basiak, M.; Kosowski, M.; Hachula, M.; Okopien, B. Plasma concentrations of cytokines in patients with combined hyperlipidemia and atherosclerotic plaque before treatment initiation-a pilot study. Medicina 2022, 58, 624. [CrossRef] [PubMed]
  59. Manhart, S.S.; Reinhardt, R.A.; Payne, J.B.; Seymour, G.J.; Gemmell, E.; Dyer, J.K.; Petro, T.M. Gingival cell IL-2 and IL-4 in early-onset periodontitis. J. Periodontol. 1994, 65, 807-813. [CrossRef]
  60. Tokoro, Y.; Matsuki, Y.; Yamamoto, T.; Suzuki, T.; Hara, K. Relevance of local Th2-type cytokine mRNA expression in immuno- competent infiltrates in inflamed gingival tissue to periodontal diseases. Clin. Exp. Immunol. 1997, 107, 166-174. [CrossRef]
  61. Ebersole, J.L.; Taubman, M.A. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994, 5, 112-141.
  62. Takeichi, O.; Haber, J.; Kawai, T.; Smith, D.J.; Moro, I.; Taubman, M.A. Cytokine profiles of T-lymphocytes from gingival tissues with pathological pocketing. J. Dent. Res. 2000, 79, 1548-1555. [CrossRef]
  63. Ukai, T.; Mori, Y.; Onoyama, M.; Hara, Y. Immunohistological study of interferon-γ-and interleukin-4-bearing cells in human periodontitis gingiva. Arch. Oral Biol. 2001, 46, 901-908. [CrossRef]
  64. Malcolm, J.; Awang, R.A.R.; Oliver-Bell, J.; Butcher, J.; Campbell, L.; Planell, A.A.; Lappin, D.; Fukada, S.; Nile, C.; Liew, F.; et al. IL-33 Exacerbates Periodontal Disease through Induction of RANKL. J. Dent. Res. 2015, 94, 968-975. [CrossRef]
  65. Sa ǧlam, M.; Köseo ǧlu, S.; Aral, C.A.; Savran, L.; Pekba ǧrıyanık, T.; Çetinkaya, A. Increased levels of interleukin-33 in gingival crevicular fluids of patients with chronic periodontitis. Odontology 2017, 105, 184-190. [CrossRef] [PubMed]
  66. Gegen, T.; Zhu, Y.; Sun, Q.; Hou, B. Role of interleukin-33 in the clinical pathogenesis of chronic apical periodontitis. J. Int. Med. Res. 2019, 47, 3332-3343. [CrossRef] [PubMed]
  67. Zenobia, C.; Hajishengallis, G. Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000 2015, 69, 142-159. [CrossRef] [PubMed]
  68. Wilharm, A.; Binz, C.; Sandrock, I.; Rampoldi, F.; Lienenklaus, S.; Blank, E.; Winkel, A.; Demera, A.; Hovav, A.-H.; Stiesch, M.; et al. Interleukin-17 is disease promoting in early stages and protective in late stages of experimental periodontitis. PLoS ONE. 2022, 17, e0265486. [CrossRef]
  69. Kotla, S.; Singh, N.K.; Heckle, M.R.; Tigyi, G.J.; Rao, G.N. The transcription factor CREB enhances interleukin-17A production and inflammation in a mouse model of atherosclerosis. Sci. Signal. 2013, 6, ra83. [CrossRef]
  70. Lim, H.; Kim, Y.U.; Sun, H.; Lee, J.H.; Reynolds, J.M.; Hanabuchi, S.; Wu, H.; Teng, B.B.; Chung, Y. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity 2014, 40, 153-165. [CrossRef] [PubMed]
  71. Taleb, S.; Romain, M.; Ramkhelawon, B.; Uyttenhove, C.; Pasterkamp, G.; Herbin, O.; Esposito, B.; Perez, N.; Yasukawa, H.; Van Snick, J.; et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 2009, 206, 2067-2077. [CrossRef]
  72. Abbas, A.; Gregersen, I.; Holm, S.; Daissormont, I.; Bjerkeli, V.; Krohg-Sørensen, K.; Skagen, K.R.; Dahl, T.B.; Russell, D.; Almås, T.; et al. Interleukin 23 levels are increased in carotid atherosclerosis: Possible role for the interleukin 23/interleukin 17 axis. Stroke 2015, 46, 793-799. [CrossRef] [PubMed]
  73. Pan, W.; Wang, Q.; Chen, Q. The cytokine network involved in the host immune response to periodontitis. Int. J. Oral Sci. 2019, 11, 30. [CrossRef]
  74. Fraser, D.; Caton, J.; Benoit, D.S.W. Periodontal wound healing and regeneration: Insights for engineering new therapeutic approaches. Front. Dent. Med. 2022, 3, 815810. [CrossRef]
  75. Skaleric, U.; Kramar, B.; Petelin, M.; Pavlica, Z.; Wahl, S.M. Changes in TGF-beta 1 levels in gingiva, crevicular fluid and serum associated with periodontal inflammation in humans and dogs. Eur. J. Oral Sci. 1997, 105, 136-142. [CrossRef] [PubMed]
  76. Berberich, A.J.; Hegele, R. A modern approach to dyslipidemia. Endocr. Rev. 2022, 43, 611-653. [CrossRef]
  77. Hasheminasabgorji, E.; Jha, J.C. Dyslipidemia, diabetes and atherosclerosis: Role of inflammation and ROS-Redox-Sensitive factors. Biomedicines 2021, 9, 1602. [CrossRef]
  78. Sheha, D.; El-Korashi, L.; AbdAllah, A.M.; El Begermy, M.M.; Elzoghby, D.M.; Elmahdi, A. Lipid profile and IL-17A in allergic rhinitis: Correlation with disease severity and quality of life. J. Asthma. Allergy. 2021, 14, 109-111. [CrossRef] [PubMed]
  79. Martínez-García, M.; Hernández-Lemus, E. Periodontal inflammation and systemic diseases: An overview. Front. Physiol. 2021, 12, 709438. [CrossRef]
  80. Sun, X.J.; Meng, H.X.; Shi, D.; Xu, L.; Zhang, L.; Chen, Z.B.; Feng, X.H.; Lu, R.F.; Ren, X.Y. Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis. J. Periodontal. Res. 2009, 44, 311-316. [CrossRef]
  81. Toprak, A.; Kandavar, R.; Toprak, D.; Chen, W.; Srinivasan, S.; Xu, J.H.; Anwar, A.; Berenson, G.S. C-reactive protein is an independent predictor for carotid artery intima-media thickness progression in asymptomatic younger adults (from the Bogalusa Heart Study). BMC Cardiovasc. Disord. 2011, 11, 78. [CrossRef] [PubMed]
  82. Elbelkimy, M.; ELkhayat, N.; ElSadek, A.; Mansour, A.; Aboutaleb, M. Predictive value of C-reactive protein and carotid intimal medial thickness in acute ischemic stroke. Egypt J. Neurol. Psychiatry Neurosurg. 2019, 55, 72. [CrossRef]
  83. Sproston, N.R.; Ashworth, J.J. Role of C-Reactive protein at sites of inflammation and infection. Front. Immunol. 2018, 9, 754. [CrossRef]
  84. Abraham, S.; Premnath, A.; Arunima, P.R.; Kassim, R.M. Critical appraisal of bidirectional relationship between periodontitis and hyperlipidemia. J. Int. Soc. Prev. Community Dent. 2019, 9, 112-118. [CrossRef] [PubMed]
  85. Nepomuceno, R.; Pigossi, S.C.; Finoti, L.S.; Orrico, S.R.P.; Cirelli, J.A.; Barros, S.P.; Offenbacher, S.; Scarel-Caminaga, R.M. Serum lipid levels in patients with periodontal disease: A meta-analysis and meta-regression. J. Clin. Periodontol. 2017, 44, 1192-1207.
  86. Yeun, Y.R.; Kwak, Y.S.; Kim, H.Y. Association serum lipid levels with periodontal disease in Korean adults over the age of 50: The Korea National health and nutrition examination survey, 2016-2018. Exerc. Sci. 2022, 31, 312-318. [CrossRef]
  87. Iacopino, A.M.; Cutler, C.W. Pathophysiological relationships between periodontitis and systemic disease: Recent concepts involving serum lipids. J. Periodontol. 2000, 71, 1375-1384. [CrossRef]
  88. Mai, J.; Nanayakkara, G.; Lopez-Pastrana, J.; Li, X.; Li, Y.-F.; Wang, X.; Song, A.; Virtue, A.; Shao, Y.; Shan, H.; et al. Interleukin-17A Promotes Aortic Endothelial Cell Activation via Transcriptionally and Post-translationally Activating p38 Mitogen-activated Protein Kinase (MAPK) Pathway. J. Biol. Chem. 2016, 291, 4939-4954. [CrossRef]
  89. Meehan, E.V.; Wang, K. Interleukin-17 family cytokines in metabolic disorders and cancer. Genes 2022, 13, 1643. [CrossRef] [PubMed]
  90. Cutler, C.W.; Shinedling, E.A.; Nunn, M.; Jotwani, R.; Kim, B.O.; Nares, S.; Iacopino, A.M. Association between periodontitis and hyperlipidemia: Cause or effect? J. Periodontol. 1999, 70, 1429-1434. [CrossRef] [PubMed]
  91. Rodean, I.P.; Lazar, L.; Halatiu, V.B.; Biris, C.; Benedek, I.; Benedek, T. Periodontal disease is associated with increased vulnerability of coronary atheromatous plaques in patients undergoing coronary computed tomography angiography-results from the Atherodent study. J. Clin. Med. 2021, 10, 1290. [CrossRef] [PubMed]
  92. Disclaimer/Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.